A Non-Conventional Epigenetic Engineering Strategy: The ALKBH5/ITGB5 Axis Enhances Recombinant Protein Production in CHO Cells through FAK-Mediated Proliferation and Improved Redox Status
ACS Synthetic Biology · 2026
DOI: 10.1021/acssynbio.6c00520 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Zhao-Ming Cui und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Henan Medical University, Xinxiang, Henan453003, China. Hauptthemen laut MEDLINE: Recombinant Proteins, AlkB Homolog 5, RNA Demethylase, Integrin beta Chains, Focal Adhesion Kinase 1. Die Arbeit nennt 58 Literaturangaben. Gefördert von: Project of Technology Innovation Leading Talent in Central Plain, The Science and Technology Research and Development Plan Joint Fund (Industry) of Henan Province, Key Research & Development Projects of Henan Province.
Abstract (Originalsprache)
Chinese hamster ovary (CHO) cells are the predominant host for producing complex recombinant therapeutic proteins. N6-methyladenosine (m6A) regulates recombinant protein production in CHO cells by influencing RNA stability and translation; however, the role of the m6A demethylase ALKBH5 remains poorly characterized in this context. Here, ALKBH5 overexpression increased the titers of three recombinant products by up to 2.87-fold, enhanced CHO cell proliferation, and reduced oxidative stress. Co-immunoprecipitation supported an association between ALKBH5 and ITGB5, and structure-guided mutagenesis identified Tyr205 of ITGB5 as functionally important for this association and ITGB5 protein stability. ALKBH5 overexpression did not measurably alter ITGB5 mRNA stability or m6A enrichment, supporting a mechanism that does not involve detectable m6A changes on the ITGB5 transcript, while not excluding m6A-dependent effects on other targets. FAK inhibition attenuated but did not abolish the production advantage, indicating that FAK signaling contributes to, but may not fully account for, the ALKBH5−ITGB5-associated phenotype. Metabolic and redox measurements further linked ALKBH5 overexpression to increased antioxidant capacity and ATP abundance, together with altered nutrient consumption and by-product formation. These findings identify ALKBH5 as a candidate host-cell engineering target for improving recombinant protein production and support further validation under industry-relevant fed-batch conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Henan Medical University, Xinxiang, Henan453003, China.
- Department of Biomedical Sciences, Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, Bertam, Kepala Batas, Penang13200, Malaysia.
- International Joint Laboratory of Recombinant Drug Protein Expression System, Henan Medical University, Xinxiang, Henan453003, China.
- Henan Engineering Research Center for Biopharmaceutical Innovation, Henan Medical University, Xinxiang, Henan453003, China.
- The Second Affiliated Hospital, Henan Medical University, Xinxiang, Henan453002, China.
- State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin300071, China.
ORCID-Profile: Ju-Fang Wang, Tian-Yun Wang, Yan-Long Jia
Förderung
- Project of Technology Innovation Leading Talent in Central Plain
- The Science and Technology Research and Development Plan Joint Fund (Industry) of Henan Province
- Key Research & Development Projects of Henan Province
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Cui, Z. M., Lu, J. T., Gao, Y. P., Guo, Y., Gao, Y. Q., Xu, Y. Y., Ye, Z. Q., Mohd Shahpudin, S. N., Feng, Y. Y., Qiu, L. L., Zhao, C. P., Wang, J. F., Hua, Z. C., Ismail, I. S., Wang, T. Y., & Jia, Y. L. (2026). A Non-Conventional Epigenetic Engineering Strategy: The ALKBH5/ITGB5 Axis Enhances Recombinant Protein Production in CHO Cells through FAK-Mediated Proliferation and Improved Redox Status. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00520
Vancouver
Cui ZM, Lu JT, Gao YP, Guo Y, Gao YQ, Xu YY, et al. A Non-Conventional Epigenetic Engineering Strategy: The ALKBH5/ITGB5 Axis Enhances Recombinant Protein Production in CHO Cells through FAK-Mediated Proliferation and Improved Redox Status. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00520
BibTeX
@article{Cui2026,
author = {Cui, Zhao-Ming and Lu, Jiang-Tao and Gao, Yan-Ping and Guo, Yang and Gao, Yin-Qi and Xu, Yuan-Ye and Ye, Zhi-Qing and Mohd Shahpudin, Siti Nurfatimah and Feng, Ying-Ying and Qiu, Le-Le and Zhao, Chun-Peng and Wang, Ju-Fang and Hua, Zi-Chun and Ismail, Ida Shazrina and Wang, Tian-Yun and Jia, Yan-Long},
title = {A Non-Conventional Epigenetic Engineering Strategy: The ALKBH5/ITGB5 Axis Enhances Recombinant Protein Production in CHO Cells through FAK-Mediated Proliferation and Improved Redox Status},
journal = {ACS Synthetic Biology},
year = {2026},
doi = {10.1021/acssynbio.6c00520}
}
EUVIMED